Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Gastroenterology. 2012 Jan 31;142(5):1218–1228.e1. doi: 10.1053/j.gastro.2012.01.032

Figure 5.

Figure 5

In vivo treatment of mice with the chemical chaperone PBA (1 g · kg−1 · day−1 for 20 days, solid symbols) reverses (A) obesity-induced glucose intolerance, (B) insulin resistance, and (C) down-regulation of IDE in the liver. *P < .05 from corresponding value in vehicle-treated mice; #P < .05 relative to corresponding STD values.